SCHEMBL31363911

SCHEMBL31363911

C#CCNC(=O)c1cnn(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ LMNA P02545 4/20 0.53
▸ HPGD P15428 2/20 0.53
▸ GRN P28799 1/20 0.49
▸ SORT1 Q99523 1/20 0.49
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ NAMPT P43490 1/20 0.42
▸ DHX9 Q08211 1/20 0.42
▸ MAPT P10636 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KDM1A O60341 2/20 0.39
▸ RCOR1 Q9UKL0 2/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3318854 0.81 SMN1; SMN2 (0.60) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL31534794 0.80 CA12 (0.42) SMN1; SMN2LMNAHPGDCA12CA1
SCHEMBL22993585 0.80 SMN1; SMN2 (0.58) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL1458487 0.80 SMN1; SMN2 (0.62) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL2828757 0.78 SMN1; SMN2 (0.55) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL23977122 0.76 KDM1A (0.55) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL27897764 0.76 SMN1; SMN2 (0.55) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL28767700 0.75 SMN1; SMN2 (0.53) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL15455083 0.75 SMN1; SMN2 (0.56) SMN1; SMN2LMNAHPGDGRNSORT1
SCHEMBL357320 0.75 SMN1; SMN2 (0.53) SMN1; SMN2LMNAHPGDGRNSORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059074-A1 BICYCLIC COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION PMV PHARMACEUTICALS, INC. (US) 2025-03-20 — — WO disclosed
Send feedback